TY - JOUR AU - Zuehlke, A. AU - Johnson, J. L. PY - 2010 DA - 2010// TI - Hsp90 and co-chaperones twist the functions of diverse client proteins JO - Biopolymers VL - 93 UR - https://doi.org/10.1002/bip.21292 DO - 10.1002/bip.21292 ID - Zuehlke2010 ER - TY - JOUR AU - da Silva, V. C. AU - Ramos, C. H. PY - 2012 DA - 2012// TI - The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: A target for cancer therapeutics JO - J Proteomics VL - 75 UR - https://doi.org/10.1016/j.jprot.2011.12.028 DO - 10.1016/j.jprot.2011.12.028 ID - da Silva2012 ER - TY - JOUR AU - Neckers, L. AU - Workman, P. PY - 2012 DA - 2012// TI - Hsp90 molecular chaperone inhibitors: are we there yet? JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-1000 DO - 10.1158/1078-0432.CCR-11-1000 ID - Neckers2012 ER - TY - JOUR AU - Whitesell, L. AU - Lin, N. U. PY - 2012 DA - 2012// TI - HSP90 as a platform for the assembly of more effective cancer chemotherapy JO - Biochim Biophys Acta VL - 1823 UR - https://doi.org/10.1016/j.bbamcr.2011.12.006 DO - 10.1016/j.bbamcr.2011.12.006 ID - Whitesell2012 ER - TY - JOUR AU - Maloney, A. AU - Clarke, P. A. AU - Workman, P. PY - 2003 DA - 2003// TI - Genes and proteins governing the cellular sensitivity to HSP90 inhibitors: a mechanistic perspective JO - Curr Cancer Drug Targets VL - 3 UR - https://doi.org/10.2174/1568009033481822 DO - 10.2174/1568009033481822 ID - Maloney2003 ER - TY - JOUR AU - Messaoudi, S. AU - Peyrat, J. F. AU - Brion, J. D. AU - Alami, M. PY - 2011 DA - 2011// TI - Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010 JO - Expert Opin Ther Pat VL - 21 UR - https://doi.org/10.1517/13543776.2011.594041 DO - 10.1517/13543776.2011.594041 ID - Messaoudi2011 ER - TY - JOUR AU - Kabakov, A. E. AU - Kudryavtsev, V. A. PY - 2010 DA - 2010// TI - Pharmacological inhibition of Hsp90: Promising approaches to targeted therapy of cancer JO - Current Topics in Pharmacology VL - 14 ID - Kabakov2010 ER - TY - JOUR AU - Mayer, M. P. AU - Bukau, B. PY - 2005 DA - 2005// TI - Hsp70 chaperones: cellular functions and molecular mechanism JO - Cell Mol Life Sci VL - 62 UR - https://doi.org/10.1007/s00018-004-4464-6 DO - 10.1007/s00018-004-4464-6 ID - Mayer2005 ER - TY - JOUR AU - Daugaard, M. AU - Rohde, M. AU - Jaattela, M. PY - 2007 DA - 2007// TI - The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions JO - FEBS Lett VL - 581 UR - https://doi.org/10.1016/j.febslet.2007.05.039 DO - 10.1016/j.febslet.2007.05.039 ID - Daugaard2007 ER - TY - JOUR AU - Whitesell, L. AU - Bagatell, R. AU - Falsey, R. PY - 2003 DA - 2003// TI - The stress response: implications for the clinical development of hsp90 inhibitors JO - Curr Cancer Drug Targets VL - 3 UR - https://doi.org/10.2174/1568009033481787 DO - 10.2174/1568009033481787 ID - Whitesell2003 ER - TY - JOUR AU - Dakappagari, N. AU - Neely, L. AU - Tangri, S. AU - Lundgren, K. AU - Hipolito, L. AU - Estrellado, A. AU - Burrows, F. AU - Zhang, H. PY - 2010 DA - 2010// TI - An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors JO - Biomarkers VL - 15 UR - https://doi.org/10.3109/13547500903261347 DO - 10.3109/13547500903261347 ID - Dakappagari2010 ER - TY - JOUR AU - Ying, W. AU - Du, Z. AU - Sun, L. AU - Foley, K. P. AU - Proia, D. A. AU - Blackman, R. K. AU - Zhou, D. AU - Inoue, T. AU - Tatsuta, N. AU - Sang, J. PY - 2012 DA - 2012// TI - Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0755 DO - 10.1158/1535-7163.MCT-11-0755 ID - Ying2012 ER - TY - JOUR AU - Wang, Y. AU - Trepel, J. B. AU - Neckers, L. M. AU - Giaccone, G. PY - 2010 DA - 2010// TI - STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer JO - Curr Opin Investig Drugs VL - 11 ID - Wang2010 ER - TY - JOUR AU - Proia, D. A. AU - Blackman, R. K. AU - Foley, K. P. AU - He, S. AU - Kepros, J. AU - Korbut, T. AU - Sang, J. AU - Smith, D. AU - Ying, W. AU - Zhang, C. PY - 2010 DA - 2010// TI - The next generation Hsp90 inhibitor STA-9090, currently in phase 2 trials, displays potent in vitro and in vivo activity JO - Ann Oncol VL - 21 ID - Proia2010 ER - TY - JOUR AU - Proia, D. A. AU - Foley, K. P. AU - Korbut, T. AU - Sang, J. AU - Smith, D. AU - Bates, R. C. AU - Liu, Y. AU - Rosenberg, A. F. AU - Zhou, D. AU - Koya, K. PY - 2011 DA - 2011// TI - Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0018552 DO - 10.1371/journal.pone.0018552 ID - Proia2011 ER - TY - CHAP AU - Acquaviva, J. AU - Sang, J. AU - Sequeira, M. AU - Smith, D. AU - Zhang, C. AU - Lovly, C. AU - Wada, Y. AU - Blackman, R. K. AU - DA, P. PY - 2011 DA - 2011// TI - Potent anticancer actions of the Hsp90 inhibitor STA-9090 in wild-type EGFR models of lung cancer BT - Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; Orlando, Florida ID - Acquaviva2011 ER - TY - JOUR AU - Proia, D. A. AU - Sang, J. AU - He, S. AU - Smith, D. L. AU - Sequeira, M. AU - Zhang, C. AU - Liu, Y. AU - Ye, S. AU - Zhou, D. AU - Blackman, R. K. PY - 2012 DA - 2012// TI - Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models JO - Invest New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-011-9790-6 DO - 10.1007/s10637-011-9790-6 ID - Proia2012 ER - TY - JOUR AU - Ramanathan, R. K. AU - Egorin, M. J. AU - Erlichman, C. AU - Remick, S. C. AU - Ramalingam, S. S. AU - Naret, C. AU - Holleran, J. L. AU - TenEyck, C. J. AU - Ivy, S. P. AU - Belani, C. P. PY - 2010 DA - 2010// TI - Phase I pharmacokinetic and pharmacodynamic study of 17- dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.0415 DO - 10.1200/JCO.2009.25.0415 ID - Ramanathan2010 ER - TY - JOUR AU - Sequist, L. V. AU - Gettinger, S. AU - Senzer, N. N. AU - Martins, R. G. AU - Janne, P. A. AU - Lilenbaum, R. AU - Gray, J. E. AU - Iafrate, A. J. AU - Katayama, R. AU - Hafeez, N. PY - 2010 DA - 2010// TI - Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.30.8338 DO - 10.1200/JCO.2010.30.8338 ID - Sequist2010 ER - TY - JOUR AU - Lancet, J. E. AU - Gojo, I. AU - Burton, M. AU - Quinn, M. AU - Tighe, S. M. AU - Kersey, K. AU - Zhong, Z. AU - Albitar, M. X. AU - Bhalla, K. AU - Hannah, A. L. PY - 2010 DA - 2010// TI - Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.292 DO - 10.1038/leu.2009.292 ID - Lancet2010 ER - TY - JOUR AU - Rajan, A. AU - Kelly, R. J. AU - Trepel, J. B. AU - Kim, Y. S. AU - Alarcon, S. V. AU - Kummar, S. AU - Gutierrez, M. AU - Crandon, S. AU - Zein, W. M. AU - Jain, L. PY - 2011 DA - 2011// TI - A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0821 DO - 10.1158/1078-0432.CCR-11-0821 ID - Rajan2011 ER - TY - JOUR AU - Crosnier, C. AU - Stamataki, D. AU - Lewis, J. PY - 2006 DA - 2006// TI - Organizing cell renewal in the intestine: stem cells, signals and combinatorial control JO - Nat Rev Genet VL - 7 UR - https://doi.org/10.1038/nrg1840 DO - 10.1038/nrg1840 ID - Crosnier2006 ER - TY - JOUR AU - Abud, H. E. AU - Watson, N. AU - Heath, J. K. PY - 2005 DA - 2005// TI - Growth of intestinal epithelium in organ culture is dependent on EGF signalling JO - Exp Cell Res VL - 303 UR - https://doi.org/10.1016/j.yexcr.2004.10.006 DO - 10.1016/j.yexcr.2004.10.006 ID - Abud2005 ER - TY - JOUR AU - Suzuki, A. AU - Sekiya, S. AU - Gunshima, E. AU - Fujii, S. AU - Taniguchi, H. PY - 2010 DA - 2010// TI - EGF signaling activates proliferation and blocks apoptosis of mouse and human intestinal stem/progenitor cells in long term monolayer cell culture JO - Lab Invest VL - 90 UR - https://doi.org/10.1038/labinvest.2010.150 DO - 10.1038/labinvest.2010.150 ID - Suzuki2010 ER - TY - JOUR AU - Wu, W. C. AU - Wu, M. H. AU - Chang, Y. C. AU - Hsieh, M. C. AU - Wu, H. J. AU - Cheng, K. C. AU - Lai, Y. H. AU - Kao, Y. H. PY - 2010 DA - 2010// TI - Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells JO - Exp Eye Res VL - 91 UR - https://doi.org/10.1016/j.exer.2010.05.005 DO - 10.1016/j.exer.2010.05.005 ID - Wu2010 ER - TY - JOUR AU - Ryhanen, T. AU - Mannermaa, E. AU - Oksala, N. AU - Viiri, J. AU - Paimela, T. AU - Salminen, A. AU - Atalay, M. AU - Kaarniranta, K. PY - 2008 DA - 2008// TI - Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells JO - Eur J Pharmacol VL - 584 UR - https://doi.org/10.1016/j.ejphar.2008.02.010 DO - 10.1016/j.ejphar.2008.02.010 ID - Ryhanen2008 ER - TY - JOUR AU - Pacey, S. AU - Wilson, R. H. AU - Walton, M. AU - Eatock, M. M. AU - Hardcastle, A. AU - Zetterlund, A. AU - Arkenau, H. T. AU - Moreno-Farre, J. AU - Banerji, U. AU - Roels, B. PY - 2011 DA - 2011// TI - A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1927 DO - 10.1158/1078-0432.CCR-10-1927 ID - Pacey2011 ER - TY - JOUR AU - Zhou, D. AU - Liu, Y. AU - Ye, J. AU - Ying, W. AU - Zhang, S. AU - Ogawa, L. AU - Inoue, T. AU - Tatsuta, N. AU - Wada, Y. AU - Sonderfan, A. PY - 2011 DA - 2011// TI - A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.TARG-11-C212 DO - 10.1158/1535-7163.TARG-11-C212 ID - Zhou2011 ER - TY - JOUR AU - Grbovic, O. M. AU - Basso, A. D. AU - Sawai, A. AU - Ye, Q. AU - Friedlander, P. AU - Solit, D. AU - Rosen, N. PY - 2006 DA - 2006// TI - V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors JO - Proc Natl Acad Sci U S A VL - 103 UR - https://doi.org/10.1073/pnas.0609973103 DO - 10.1073/pnas.0609973103 ID - Grbovic2006 ER - TY - JOUR AU - Matei, D. AU - Satpathy, M. AU - Cao, L. AU - Lai, Y. C. AU - Nakshatri, H. AU - Donner, D. B. PY - 2007 DA - 2007// TI - The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M607012200 DO - 10.1074/jbc.M607012200 ID - Matei2007 ER - TY - JOUR AU - da Rocha, D. S. AU - Friedlos, F. AU - Light, Y. AU - Springer, C. AU - Workman, P. AU - Marais, R. PY - 2005 DA - 2005// TI - Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-2632 DO - 10.1158/0008-5472.CAN-05-2632 ID - da Rocha2005 ER - TY - JOUR AU - Dewaele, B. AU - Wasag, B. AU - Cools, J. AU - Sciot, R. AU - Prenen, H. AU - Vandenberghe, P. AU - Wozniak, A. AU - Schoffski, P. AU - Marynen, P. AU - Debiec-Rychter, M. PY - 2008 DA - 2008// TI - Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0533 DO - 10.1158/1078-0432.CCR-08-0533 ID - Dewaele2008 ER - TY - JOUR AU - Brodsky, J. L. AU - Chiosis, G. PY - 2006 DA - 2006// TI - Hsp70 molecular chaperones: emerging roles in human disease and identification of small molecule modulators JO - Curr Top Med Chem VL - 6 UR - https://doi.org/10.2174/156802606777811997 DO - 10.2174/156802606777811997 ID - Brodsky2006 ER - TY - JOUR AU - Yun, C. H. AU - Yoon, S. Y. AU - Nguyen, T. T. AU - Cho, H. Y. AU - Kim, T. H. AU - Kim, S. T. AU - Kim, B. C. AU - Hong, Y. S. AU - Kim, S. J. AU - Lee, H. J. PY - 2010 DA - 2010// TI - Geldanamycin inhibits TGF-beta signaling through induction of Hsp70 JO - Arch Biochem Biophys VL - 495 UR - https://doi.org/10.1016/j.abb.2009.12.003 DO - 10.1016/j.abb.2009.12.003 ID - Yun2010 ER - TY - JOUR AU - Okui, T. AU - Shimo, T. AU - Hassan, N. M. AU - Fukazawa, T. AU - Kurio, N. AU - Takaoka, M. AU - Naomoto, Y. AU - Sasaki, A. PY - 2011 DA - 2011// TI - Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma JO - Anticancer Res VL - 31 ID - Okui2011 ER - TY - JOUR AU - Banerji, U. AU - Walton, M. AU - Raynaud, F. AU - Grimshaw, R. AU - Kelland, L. AU - Valenti, M. AU - Judson, I. AU - Workman, P. PY - 2005 DA - 2005// TI - Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0518 DO - 10.1158/1078-0432.CCR-05-0518 ID - Banerji2005 ER - TY - JOUR AU - Goetz, M. P. AU - Toft, D. AU - Reid, J. AU - Ames, M. AU - Stensgard, B. AU - Safgren, S. AU - Adjei, A. A. AU - Sloan, J. AU - Atherton, P. AU - Vasile, V. PY - 2005 DA - 2005// TI - Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.119 DO - 10.1200/JCO.2005.09.119 ID - Goetz2005 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/152/prepub UR - http://www.biomedcentral.com/1471-2407/13/152/prepub ID - ref38 ER -